1289 related articles for article (PubMed ID: 22208383)
1. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
2. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
3. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation.
Khalil IA; Futaki S; Niwa M; Baba Y; Kaji N; Kamiya H; Harashima H
Gene Ther; 2004 Apr; 11(7):636-44. PubMed ID: 14973542
[TBL] [Abstract][Full Text] [Related]
5. Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells.
Ma DX; Shi NQ; Qi XR
Int J Pharm; 2011 Oct; 419(1-2):200-8. PubMed ID: 21843610
[TBL] [Abstract][Full Text] [Related]
6. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
Futaki S; Nakase I
Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
[TBL] [Abstract][Full Text] [Related]
7. Distinct uptake routes of cell-penetrating peptide conjugates.
Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
[TBL] [Abstract][Full Text] [Related]
8. Acylation of octaarginine: Implication to the use of intracellular delivery vectors.
Katayama S; Hirose H; Takayama K; Nakase I; Futaki S
J Control Release; 2011 Jan; 149(1):29-35. PubMed ID: 20144669
[TBL] [Abstract][Full Text] [Related]
9. Oligoarginine-PEG-lipid particles for gene delivery.
Maitani Y; Hattori Y
Expert Opin Drug Deliv; 2009 Oct; 6(10):1065-77. PubMed ID: 19637981
[TBL] [Abstract][Full Text] [Related]
10. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
11. A peptide-based vector for efficient gene transfer in vitro and in vivo.
Lehto T; Simonson OE; Mäger I; Ezzat K; Sork H; Copolovici DM; Viola JR; Zaghloul EM; Lundin P; Moreno PM; Mäe M; Oskolkov N; Suhorutšenko J; Smith CI; Andaloussi SE
Mol Ther; 2011 Aug; 19(8):1457-67. PubMed ID: 21343913
[TBL] [Abstract][Full Text] [Related]
12. Influence of stearyl and trifluoromethylquinoline modifications of the cell penetrating peptide TP10 on its interaction with a lipid membrane.
Anko M; Majhenc J; Kogej K; Sillard R; Langel U; Anderluh G; Zorko M
Biochim Biophys Acta; 2012 Mar; 1818(3):915-24. PubMed ID: 22240008
[TBL] [Abstract][Full Text] [Related]
13. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici DM; Mäger I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CI; Lebleu B; Samir El Andaloussi ; Langel U
J Control Release; 2010 Jan; 141(1):42-51. PubMed ID: 19744531
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of cell-penetrating peptides.
Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
[TBL] [Abstract][Full Text] [Related]
15. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
[TBL] [Abstract][Full Text] [Related]
16. CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway.
Räägel H; Säälik P; Hansen M; Langel U; Pooga M
J Control Release; 2009 Oct; 139(2):108-17. PubMed ID: 19577599
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
18. Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
[TBL] [Abstract][Full Text] [Related]
19. Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
Ma Y; Gong C; Ma Y; Fan F; Luo M; Yang F; Zhang YH
J Control Release; 2012 Sep; 162(2):286-94. PubMed ID: 22824782
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
